Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000813544 | SCV000953908 | pathogenic | Developmental and epileptic encephalopathy, 14; Autosomal dominant nocturnal frontal lobe epilepsy 5 | 2018-07-08 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change alters the channels activity (PMID: 24591078, 26269628). This variant has been observed to be de novo in several individuals affected with epileptic encephalopathy (PMID: 26369628, 29186148, 25590979) and reported to segregate in a family affected with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) (PMID: 23086396) . ClinVar contains an entry for this variant (Variation ID: 39598). This variant is not present in population databases (ExAC no frequency). This sequence change replaces tyrosine with histidine at codon 796 of the KCNT1 protein (p.Tyr796His). The tyrosine residue is highly conserved and there is a moderate physicochemical difference between tyrosine and histidine. |
Duke University Health System Sequencing Clinic, |
RCV000032798 | SCV003919082 | likely pathogenic | Autosomal dominant nocturnal frontal lobe epilepsy 5 | 2023-04-20 | criteria provided, single submitter | research | |
OMIM | RCV000032798 | SCV000056566 | pathogenic | Autosomal dominant nocturnal frontal lobe epilepsy 5 | 2012-11-01 | no assertion criteria provided | literature only | |
Gene |
RCV000032798 | SCV000211890 | not provided | Autosomal dominant nocturnal frontal lobe epilepsy 5 | no assertion provided | literature only |